Current Pharmaceutical Design
Title: Editorial [Hot Topic: Architecture and Design of Non-Drug Therapy for Reactive Oxygen Spcecies (ROS)-Induced Diseases (Executive Guest Editors: Tohru Yoshioka and Mami Noda)]
Volume: 17 Issue: 22
Author(s): Tohru Yoshioka and Mami Noda
Affiliation:
Export Options
About this article
Cite this article as:
Yoshioka Tohru and Noda Mami, Editorial [Hot Topic: Architecture and Design of Non-Drug Therapy for Reactive Oxygen Spcecies (ROS)-Induced Diseases (Executive Guest Editors: Tohru Yoshioka and Mami Noda)], Current Pharmaceutical Design 2011; 17 (22) . https://dx.doi.org/10.2174/138161211797052691
DOI https://dx.doi.org/10.2174/138161211797052691 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cultivating Software Solutions Development in the Scientific Academia
Recent Patents on Computer Science Visualising Neuroinflammation in Post-Stroke Patients: A Comparative PET Study with the TSPO Molecular Imaging Biomarkers [<sup>11</sup>C]PK11195 and [<sup>11</sup>C]vinpocetine
Current Radiopharmaceuticals Inhibitory Effect of Selective Cyclooxygenase-2 Inhibitor Etoricoxib on Human Organic Anion Transporter 3 (hOAT3)
Drug Metabolism Letters Difference in Blood Pressure Measurements Between Arms: Methodological and Clinical Implications
Current Pharmaceutical Design Site-related Effects of Relaxin in the Gastrointestinal Tract Through Nitric Oxide Signalling: An Updated Report
Current Protein & Peptide Science Subclassification and Nomenclature of α- and β-Adrenoceptors
Current Topics in Medicinal Chemistry The ‘Arimidex’, Tamoxifen, Alone or in Combination (ATAC) Trial: A Step Forward in the Treatment of Early Breast Cancer
Reviews on Recent Clinical Trials Toll-Like Receptors: Sensor Molecules for Detecting Damage to the Nervous System
Current Protein & Peptide Science The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib
Current Pharmaceutical Design Sobetirome: A Selective Thyromimetic for the Treatment of Dyslipidemia
Recent Patents on Cardiovascular Drug Discovery The Developing Role of Neuregulin1 In Cardiac Regenerative Stem Cell Therapy
Current Pharmaceutical Design Current Inhibition Concepts of Zinc Metallopeptidases Involved in Blood Pressure Regulation
Current Enzyme Inhibition Emerging Therapies for Diabetic Neuropathy: A Clinical Overview
Current Diabetes Reviews PPAR Ligands Containing Stilbene Scaffold
Mini-Reviews in Medicinal Chemistry Renal Effects of Non-Steroidal Anti-Inflammatory Drugs and Selective Cyclooxygenase-2 Inhibitors
Current Pharmaceutical Design Postpartum Posterior Reversible Encephalopathy Syndrome in a Patient Suspected to COVID-19
Anti-Infective Agents Myocardial ‘No-Reflow’ Prevention
Current Vascular Pharmacology TRP Channels as Therapeutic Targets in Kidney Disease and Hypertension
Current Topics in Medicinal Chemistry Social Media as a Means to Disseminate and Advocate Cardiovascular Research: Why, How, and Best Practices
Current Cardiology Reviews The Glutamatergic Neurotransmission in the Central Nervous System
Current Medicinal Chemistry